A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer

Clinical trial NCT05723562 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05723562
Sponsor: GlaxoSmithKline
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Rectal

Start date: 2023-04-03
Primary completion: 2026-11-02
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.